Dose-dependent increases in heart rate were also observed, consistent with the glucagon receptor agonism component of the drug, and this warrants careful monitoring in individuals with pre-existing cardiac conditions
Therefore, the following targets are recommended: 14 LDL-cholesterol less than 2.0 mmol/L (or less than 1.8 mmol/L if CV disease is established) HDL-cholesterol greater than 1.0 mmol/L triglycerides: less than 2.0 mmol/L
After 2-4 weeks of good tolerance, the dose increases to 1-1.5 mg daily
Established habits: Patients who have genuinely adopted sustainable nutrition and exercise habits during treatment are better positioned to maintain their weight loss
While rare, its possible to experience pancreatitis (inflammation of the pancreas), kidney problems (like kidney stones), acute gallbladder disease, and an increased risk of thyroid cancer
Comprehensive Medical Evaluation Your doctor reviews your: Weight loss history and goals BMI and waist circumference Current medical conditions (diabetes, hypertension, heart disease, PCOS, etc.) Medications and allergies Lifestyle factors influencing your weight This is similar to the in-depth approach used in our virtual weight loss and telehealth obesity care programs